|
EORTC AISBL / IVZW |
The primary objective of the EORTC Quality Assurance Committee is to work closely with all quality
assurance partners from the disease oriented groups and the EORTC Headquarters Quality Systems
& Compliance Unit (QS&C) to ensure continuous improvement and development of forward thinking
in relation to quality strategies. The QAC will assess serious non-compliance issues and recommend
actions, as appropriate, to comply with Good Clinical Practice and new directives/guidelines from
Regulatory Authorities.For issues in which an allegation of scientific misconduct has been raised, the
issues are directed to the QAC, and the follow up is coordinated by the QS&C and the QAC. The
QAC ensures that appropriate actions are put in place in collaboration with the QS&C unit.
The QAC reports these issues to the EORTC Board.
Members
Chair K. Haustermans, Leuven (BE)
Secretary C. Wyns, Brussels (BE)
L. Collette, Brussels (BE)
M. den Dulk, Leiden (NL)
L. Greillier, Marseille (FR)
M. Leahy, Manchester (UK)
F. Meunier, Brussels (BE)
P. Poortmans, Tilburg (NL)
H. van Krieken, Nijmegen (NL)
Last updated 27-08-2009